Use of Influenza Risk Assessment Tool for Prepandemic Preparedness

Stephen A. Burke; Susan C. Trock

Disclosures

Emerging Infectious Diseases. 2018;24(3):471-477. 

In This Article

Abstract and Introduction

Abstract

In 2010, the Centers for Disease Control and Prevention began to develop an Influenza Risk Assessment Tool (IRAT) to methodically capture and assess information relating to influenza A viruses not currently circulating among humans. The IRAT uses a multiattribute, additive model to generate a summary risk score for each virus. Although the IRAT is not intended to predict the next pandemic influenza A virus, it has provided input into prepandemic preparedness decisions.

Introduction

Planning and preparation for influenza pandemics are major challenges to public health authorities for many reasons, not the least of which is the inherent variability and unpredictability of the influenza virus.[1] Just in the past decade, infections from multiple new influenza viruses have occurred in humans, representing influenza A subtypes such as H1N2, H3N2v, H5N1, H5N6, H6N1, H7N2, H7N3, H7N7, H7N9, H9N2, and H10N8. In response to these findings, prepandemic vaccines were developed for some of these viruses.[2–5] In 2009, a new virus, subsequently designated influenza A(H1N1)pdm09, emerged in humans in North America and quickly spread, causing the first influenza pandemic of the 21st century.[6] Although only 3 hemagglutinin (HA) subtypes of influenza (H1, H2, and H3) are known to have caused human pandemics,[7] the emergence and spread of influenza A(H5N1) and, more recently, influenza A(H7N9), with associated high death rates in humans, are of great concern. If these or other influenza A viruses not currently circulating among humans develop the capability to transmit efficiently among humans, they pose a risk for causing a pandemic that could be associated with high rates of illness and death.[8,9]

The task of risk mitigation planning and preparedness for pandemic influenza is difficult, and a tool is needed that systematically evaluates different influenza viruses to inform decisions related to the prioritization and allocation of resources for vaccine development, influenza surveillance strategies, and research initiatives. In this context, the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) developed the Influenza Risk Assessment Tool (IRAT) with the goal to systematically evaluate influenza A viruses that are not circulating in humans but potentially pose a pandemic risk.[10]

The IRAT uses a common decision analysis approach that incorporates input from multiple elements or attributes, applies a weighting scheme, and generates a score to compare various options or decisions.[11] In regard to the evaluation of animal-origin influenza viruses for their potential human pandemic risk, 2 specific questions were developed related to the potential risk for emergence and consequent potential impact: 1) What is the risk that a virus not currently circulating in humans has the potential for sustained human-to-human transmission? (emergence question); and 2) If a virus were to achieve sustained human-to-human transmission, what is the risk that a virus not currently circulating among humans has the potential for substantial impact on public health? (impact question).

In developing the IRAT, a working group of international influenza experts in influenza virology, animal health, human health, and epidemiology identified 10 risk elements and definitions. These elements were described previously;[10] in brief, they include virus properties (genomic variation, receptor-binding properties, transmissibility in animal models, and antiviral treatment susceptibility) and host properties (population immunity, disease severity, and antigenic relationship to vaccines). The final 3 elements are based on the epidemiologic and ecologic evidence: infection in humans, infections in animals, and global distribution in animals. These elements are used to answer the 2 risk questions to evaluate an influenza virus of interest. The 10 elements are ranked and weighted on the basis of their perceived importance to answering the specific risk questions and an aggregate risk score is generated.

Since its inception, the IRAT has facilitated the evaluation of multiple viruses and contributed information to decisions related to US pandemic planning, such as selection of candidate vaccine viruses (CVVs) and vaccines for the Strategic National Stockpile of prepandemic influenza vaccines.[12] We summarize the evaluation of 14 animal viruses and discuss the strengths and limitations of the IRAT as a tool supporting CDC's Preparedness and Response Framework for Influenza Pandemics,[13] a document that outlines key public health decisions and actions to be taken at specific times during an influenza pandemic.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....